Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,585 | 9,497 | 23,587 | 36,838 | 22,088 |
| Marketable Securities | 8,977 | 21,219 | 7,154 | 1,337 | 627 |
| Receivables | 4 | 23,940 | 3,719 | 3,046 | 1,157 |
| TOTAL | $43,999 | $57,519 | $36,358 | $42,623 | $25,649 |
| Non-Current Assets | |||||
| PPE Net | 5,630 | 8,175 | 5,835 | 5,533 | 5,529 |
| Investments And Advances | 0 | 0 | 33,733 | 117,167 | 100,039 |
| Intangibles | 57,704 | 58,920 | 3,125 | 6,900 | 10,206 |
| Other Non-Current Assets | 616 | 864 | 22,609 | 1,018 | 1,149 |
| TOTAL | $63,950 | $67,959 | $65,302 | $130,618 | $116,923 |
| Total Assets | $107,949 | $125,478 | $101,660 | $173,241 | $142,572 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,813 | 5,226 | 6,463 | 5,718 | 7,144 |
| Other current liabilities | 194 | 45 | N/A | N/A | 0 |
| TOTAL | $7,769 | $6,494 | $6,812 | $6,879 | $8,850 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 18 | 120 |
| Deferred Revenues | N/A | N/A | 42 | 797 | 572 |
| Other Non-Current Liabilities | 2,987 | 4,263 | 3,048 | 5,157 | 17,377 |
| TOTAL | $5,053 | $7,737 | $2,602 | $2,099 | $3,214 |
| Total Liabilities | $12,822 | $14,231 | $9,414 | $8,978 | $12,064 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 161,638 | 149,808 | 149,361 | 126,869 | 110,854 |
| Common Shares | 393,944 | 387,062 | 354,270 | 378,487 | 317,878 |
| Retained earnings | -294,078 | -273,422 | -261,856 | -216,297 | -196,321 |
| Other shareholders' equity | -4,739 | -2,393 | -168 | 2,073 | 11,951 |
| TOTAL | $95,127 | $111,247 | $92,246 | $164,263 | $130,508 |
| Total Liabilities And Equity | $107,949 | $125,478 | $101,660 | $173,241 | $142,572 |